Annual Long Term Debt
$290.29 M
+$75.27 M+35.00%
December 31, 2023
Summary
- As of February 7, 2025, BPMC annual long term debt is $290.29 million, with the most recent change of +$75.27 million (+35.00%) on December 31, 2023.
- During the last 3 years, BPMC annual long term debt has risen by +$208.62 million (+255.44%).
- BPMC annual long term debt is now at all-time high.
Performance
BPMC Long Term Debt Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Long Term Debt
$413.45 M
-$446.00 K-0.11%
September 30, 2024
Summary
- As of February 7, 2025, BPMC quarterly long term debt is $413.45 million, with the most recent change of -$446.00 thousand (-0.11%) on September 30, 2024.
- Over the past year, BPMC quarterly long term debt has increased by +$121.26 million (+41.50%).
- BPMC quarterly long term debt is now -0.11% below its all-time high of $413.90 million, reached on June 30, 2024.
Performance
BPMC Quarterly Long Term Debt Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Long Term Debt Formula
Long-Term Debt = Bonds Payable + Long-Term Loans + Mortgage Payable + Other Long-Term Borrowings − Current Portion of Long-Term Debt
BPMC Long Term Debt Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +35.0% | +41.5% |
| 3 y3 years | +255.4% | +97.6% |
| 5 y5 years | +2149.8% | +97.6% |
BPMC Long Term Debt Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | +181.0% | -0.1% | +321.2% |
| 5 y | 5-year | at high | +255.4% | -0.1% | +450.9% |
| alltime | all time | at high | >+9999.0% | -0.1% | >+9999.0% |
Blueprint Medicines Long Term Debt History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $413.45 M(-0.1%) |
| Jun 2024 | - | $413.90 M(+43.9%) |
| Mar 2024 | - | $287.69 M(-0.9%) |
| Dec 2023 | $290.29 M(+35.0%) | $290.29 M(-0.7%) |
| Sep 2023 | - | $292.19 M(+39.7%) |
| Jun 2023 | - | $209.19 M(-1.4%) |
| Mar 2023 | - | $212.07 M(-1.4%) |
| Dec 2022 | $215.02 M(+108.1%) | $215.02 M(-1.6%) |
| Sep 2022 | - | $218.56 M(+122.7%) |
| Jun 2022 | - | $98.16 M(-2.6%) |
| Mar 2022 | - | $100.76 M(-2.5%) |
| Dec 2021 | $103.31 M(+26.5%) | $103.31 M(+37.7%) |
| Sep 2021 | - | $75.05 M(-2.9%) |
| Jun 2021 | - | $77.27 M(-2.8%) |
| Mar 2021 | - | $79.48 M(-2.7%) |
| Dec 2020 | $81.67 M(-8.4%) | $81.67 M(-2.5%) |
| Sep 2020 | - | $83.73 M(-2.3%) |
| Jun 2020 | - | $85.73 M(-2.2%) |
| Mar 2020 | - | $87.67 M(-1.6%) |
| Dec 2019 | $89.13 M | $89.13 M(-2.0%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2019 | - | $90.92 M(-1.9%) |
| Jun 2019 | - | $92.65 M(-1.8%) |
| Mar 2019 | - | $94.32 M(+631.0%) |
| Dec 2018 | $12.90 M(-11.7%) | $12.90 M(-3.2%) |
| Sep 2018 | - | $13.33 M(-3.1%) |
| Jun 2018 | - | $13.76 M(-3.0%) |
| Mar 2018 | - | $14.19 M(-2.9%) |
| Dec 2017 | $14.62 M(+239.1%) | $14.62 M(+72.7%) |
| Sep 2017 | - | $8.46 M(+128.9%) |
| Jun 2017 | - | $3.70 M(-1.5%) |
| Mar 2017 | - | $3.75 M(-12.9%) |
| Dec 2016 | $4.31 M(-42.1%) | $4.31 M(-14.3%) |
| Sep 2016 | - | $5.03 M(-12.5%) |
| Jun 2016 | - | $5.75 M(-11.1%) |
| Mar 2016 | - | $6.47 M(-13.0%) |
| Dec 2015 | $7.44 M(+1.4%) | $7.44 M(-11.5%) |
| Sep 2015 | - | $8.41 M(-10.3%) |
| Jun 2015 | - | $9.37 M(+43.6%) |
| Mar 2015 | - | $6.53 M(-11.1%) |
| Dec 2014 | $7.34 M(+240.5%) | $7.34 M |
| Dec 2013 | $2.15 M | - |
FAQ
- What is Blueprint Medicines annual long term debt?
- What is the all time high annual long term debt for Blueprint Medicines?
- What is Blueprint Medicines annual long term debt year-on-year change?
- What is Blueprint Medicines quarterly long term debt?
- What is the all time high quarterly long term debt for Blueprint Medicines?
- What is Blueprint Medicines quarterly long term debt year-on-year change?
What is Blueprint Medicines annual long term debt?
The current annual long term debt of BPMC is $290.29 M
What is the all time high annual long term debt for Blueprint Medicines?
Blueprint Medicines all-time high annual long term debt is $290.29 M
What is Blueprint Medicines annual long term debt year-on-year change?
Over the past year, BPMC annual long term debt has changed by +$75.27 M (+35.00%)
What is Blueprint Medicines quarterly long term debt?
The current quarterly long term debt of BPMC is $413.45 M
What is the all time high quarterly long term debt for Blueprint Medicines?
Blueprint Medicines all-time high quarterly long term debt is $413.90 M
What is Blueprint Medicines quarterly long term debt year-on-year change?
Over the past year, BPMC quarterly long term debt has changed by +$121.26 M (+41.50%)